cerrar
Tagged with VAT

Interview: Luis Nieto, Managing Director, Convatec Mexico
Convatec acquired Boston Medical Device in September 2011. Which have been the major challenges following the acquisition, and which synergies are to…

Interview with The Honourable Greg Combet, MP, Minister for…
Would you outline the commitment of the Ministry to foster a positive business environment for the Australian pharmaceutical industry to prosper?…

Interview with Francis Lynch, General Manager, A Menarini Ireland…
You established Menarini’s Irish affiliate in 1999. How have you seen the market evolve over these last 13 years? The major changes in the market…

Interview: Peter Erlbacher, Chief Operations Officer, Spanish…
The Aspen Group identified Latin America as a “large developing market where it can leverage its substantial intellectual property portfolio and…

Interview with Tamàs Dàvid, Deputy Director & Market…
With various new government measures, the pharmaceutical and healthcare sector in Hungary has been undergoing quite a turbulent period recently. But…

Interview with Melvin Oscar D'souza, Managing Director, Novo…
Novo Nordisk seems somewhat of an exception to the MNCs that recently entered India, as it already set up its HQ in Bangalore in 1994. How do you…

Interview with Melvin Oscar D’souza, Managing Director,…
Novo Nordisk seems somewhat of an exception to the MNCs that recently entered India, as it already set up its HQ in Bangalore in 1994. How do you…

Interview with Abdullah Al Hindawi, CEO, Private Hospitals…
The Association was founded in 1984 and has played an important role throughout the decades improving the standards of the country’s private…

Interview with Jakub Dvořáček, Executive Director, Asociace…
Mr. Dvořáček, in 2010, the AIFP commissioned a study on the economic footprint of the innovative pharmaceutical industry in the Czech Republic. Can…

Interview with Val Beaumont, Executive Director, IMSA –…
Ms Beaumont, can you describe the association to our readers and its main objectives? Innovative Medicines South Africa (IMSA) represents…

Interview: Kiran Mazumdar-Shaw, Chairman & Managing…
If we look back at the conditions under which you founded Biocon in 1978, we see a young woman with a seed capital of only Rs. 10,000 in a garage in…

Interview: Glenn Saldanha, Managing Director & CEO, Glenmark
Glenmark may be poised to release India’s first novel drug, from the in-licensed, anti-diarrheal molecule Crofelemer. Crofelemer has successfully…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here